Display options
Cite
Zis P, Dimopoulos S, Markaki V, et al. Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature. World J Cardiol. 2013;5(7):265-9doi: 10.4330/wjc.v5.i7.265.
Zis, P., Dimopoulos, S., Markaki, V., Tavernarakis, A., & Nanas, S. (2013). Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature. World journal of cardiology, 5(7), 265-9. https://doi.org/10.4330/wjc.v5.i7.265
Zis, Panagiotis, et al. "Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature." World journal of cardiology vol. 5,7 (2013): 265-9. doi: https://doi.org/10.4330/wjc.v5.i7.265
Zis P, Dimopoulos S, Markaki V, Tavernarakis A, Nanas S. Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature. World J Cardiol. 2013 Jul 26;5(7):265-9. doi: 10.4330/wjc.v5.i7.265. PMID: 23888198; PMCID: PMC3722426.
Copy Download .nbib Format: NLM
Share it on

World J Cardiol. 2013 Jul 26;5(7):265-9. doi: 10.4330/wjc.v5.i7.265.

Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature.

World journal of cardiology

Panagiotis Zis, Stavros Dimopoulos, Vasiliki Markaki, Antonios Tavernarakis, Serafim Nanas

Affiliations

  1. Panagiotis Zis, Antonios Tavernarakis, Department of Neurology, Evangelismos Hospital, 10676 Athens, Greece.

PMID: 23888198 PMCID: PMC3722426 DOI: 10.4330/wjc.v5.i7.265

Abstract

Cardiovascular adverse events in patients with myasthenia gravis (MG) are rare, but the early recognition of such events is crucial. We describe a case of a non-coronary myocardial infarction (MI) during the initial treatment period with pyridostigmine bromide in a female patient with MG. Clinicians should be cautious about the appearance of potential MI in patients with MG. A baseline electrocardiogram is advocated, when the early recognition of the MI clinical signs and the laboratory findings (myocardial markers) are vital to the immediate and appropriate management of this medical emergency, as well as to prevent future cardiovascular events. In this case report possible causes of myocardial adverse events in the context of MG, which may occur during the ongoing treatment and the clinical course of the disease, are discussed.

Keywords: Myasthenia gravis; Myocardial infarction; Pyridostigmine

References

  1. Acta Neurol Scand. 1984 Sep;70(3):176-84 - PubMed
  2. J Med Case Rep. 2010 Dec 03;4:393 - PubMed
  3. N Engl J Med. 1994 Jun 23;330(25):1797-810 - PubMed
  4. JAMA. 2005 Jan 26;293(4):477-84 - PubMed
  5. Ann Pharmacother. 2005 Dec;39(12):2114-8 - PubMed
  6. Acta Anaesthesiol Scand. 2005 Oct;49(9):1395-6 - PubMed
  7. Arch Intern Med. 1994 Feb 14;154(3):265-9 - PubMed
  8. Rinsho Shinkeigaku. 2004 Mar;44(3):207-10 - PubMed
  9. Atherosclerosis. 2005 Jul;181(1):193-9 - PubMed
  10. Case Rep Med. 2009;2009:861370 - PubMed
  11. J Med Case Rep. 2009 Jan 23;3:24 - PubMed
  12. Muscle Nerve. 2011 Dec;44(6):990-3 - PubMed
  13. Angiology. 2000 Dec;51(12):1031-4 - PubMed
  14. Ann Rheum Dis. 2000 Jan;59(1):77-80 - PubMed
  15. Int J Cardiol. 2005 Sep 1;103(3):335-7 - PubMed
  16. Int J Cardiol. 2006 May 24;109(3):427-9 - PubMed
  17. Ann N Y Acad Sci. 2007 Sep;1110:315-8 - PubMed
  18. Am Heart J. 1990 Jul;120(1):211-3 - PubMed
  19. Arch Neurol. 2009 Nov;66(11):1334-8 - PubMed
  20. Am J Cardiol. 1992 Jan 1;69(1):129-32 - PubMed
  21. Eur Heart J. 2001 Aug;22(16):1459-65 - PubMed

Publication Types